Abstract:Clinical trials of renal denervation (RDN) have shown unanticipated changes in non-renal sympathetic activity. It has been hypothesized that this is due to ablation of sympathoexcitatory afferent renal nerves, which are overactive under conditions of renal inflammation. This study sought to investigate the interaction of the inflammatory cytokine, IL-1, and afferent renal nerves in the pathogenesis of hypertension. To test this hypothesis, we compared the effect of afferent RDN (ARDN) to the administration of the IL-1R antagonist anakinra, on the pathogenesis DOCA-salt hypertension. In addition, the combination of ARDN and anakinra treatments in DOCA-salt mice was administered to assess the degree of mechanistic overlap. 10-week-old male C57BL6/J mice were implanted with radio-telemetry probes in the carotid artery for measurement of mean arterial pressure (MAP). DOCA was administered via subcutaneous implantation of a silicon pellet containing 50 mg of DOCA. Sham mice received a drug free silicon pellet. Uni-nephrectomy, pellet insertion, salt treatment, ARDN were all performed or started on the same day. ARDN was performed through peri-axonal application of capsaicin. IL-1R antagonist anakinra was used to suppress activation of IL-1R. Anakinra (75mg/kg) was delivered via intraperitoneal injection daily 10 days post induction of hypertension. Animals in the untreated or monotherapy groups received sham RDN and/or vehicle injections. Baseline MAP was measured 3 days prior to induction of DOCA-salt hypertension by radiotelemetry. MAP increased in untreated DOCA-salt mice by 42 ± 2 mmHg (n=7) from baseline in the final week of the study. In comparison, this response was attenuated by 42% by ARDN (+24 ± 2 mmHg, n=7). IL-1α and IL-1β were both increased in DOCA-salt kidneys (112.4 ± 19.2 pg/mg and 2.1 ± 0.4 pg/mg respectively) compared to sham kidneys (31.98 ± 4.4 pg/mg and 0.36 ± 0.06 pg/mg respectively). The DOCA-salt induced increase of MAP in mice treated with anakinra alone (+23 ± 3 mmHg, n=9), or the combination of ARDN and anakinra (+26 ± 3 mmHg, n=5) was similar to ARDN monotherapy (+24 ± 2 mmHg, n=7). All treatment groups showed statistically significant changes in MAP compared to the SHAM and Vehicle treated group with 2 Way ANOVA and Tukey test for multiple comparisons. The finding that ARDN and anakinra combination therapy provides no additional benefit beyond ARDN or anakinra alone, suggests a common mechanism. We propose that antagonism of IL-1R blocks IL-1 mediated activation of afferent renal nerves resulting in decreased central sympathetic tone and decreased MAP. Further investigation into the mechanisms of cytokine mediated sensory fiber activation in the kidney are the subject of ongoing studies. T32DK083250-01A1, R01HL116476 This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

PS 13-16 MATRIX METALLOPROTEINASE-2 AND PLASMINOGEN ACTIVATOR INHIBITOR-1 MAY CONTRIBUTE TO DEOXYCORTICOSTERONE-ACETATE/SALT INDUCED RENAL LESION AND

Dietary Potassium Supplementation Reduces Chronic Kidney Lesions Independent of Blood Pressure in Deoxycorticosterone-Acetate and High Sodium Chloride-Treated Mice

Abstract 8: Deletion Of The Alpha Subunit Of EnNaC And MTORC2 Inhibition Attenuate DOCA-salt-induced Endothelial Cell And Vascular Stiffness.

IMPACT OF NLRP3 INFLAMMASOME ON THE DEVELOPMENT OF HYPERTENSION AND RENAL AND CARDIAC HYPERTROPHY IN 2K1C AND DOCA/SALT MICE

Effects of Salt-Loading and Potassium Supplement on Oxidative Stress Level and Expression of P22 Phox in Dahl S Rats' Renal Medulla

Endothelial cell serum and glucocorticoid regulated kinase 1 (SGK1) mediates DOCA-salt-induced endothelial cell and arterial stiffening

Effects of salt intake and potassium supplementation on renalase expression in the kidneys of Dahl salt-sensitive rats.

Abstract P312: High Potassium Intake Aggravates Cardiovascular Damage Accompanied By Premature Senescence In Hypertensive Apolipoproteine-ko Mice Under High Salt Diet

Potassium supplement on renal medullary hypoxia-inducible factor prolyl-hydroxylase2/HIF-1α pathway in Dahl salt-sensitive rats

Effect Of Sodium And Potassium Intervention On Oxidative Stress In Circuiation And Renal Medulla Of Dahl Sait-Sensitive Rats

Effects of salt loading and potassium supplement on fibrosis and expression of TGF-β1 in Dahl S rats' renal medulla

PS-B09-13: PHARMACOLOGICAL INHIBITION OF INTERLEUKIN-18 REDUCES DEOXYCORTICOSTERONE/SALT-INDUCED HYPERTENSION AND RENAL INFLAMMATION

Lack of Collecting Duct Renin Does Not Protect Against Doca-Salt Hypertension and Renal Injury

Effects of potassium supplementation and deficiency on the progression of salt-sensitive hypertension

Collecting Duct Renin Does Not Mediate DOCA-Salt Hypertension or Renal Injury

IL-1R mediated renal sensory nerve activity drives hypertension in the DOCA-Salt mouse

Effects of Compound-ion Salt on Generation of AngII,NO and Expression of Phosphorylated ERK1/2 in Renal Cortex of Spontaneously Hypertensive Rats

Salutary Effect of Kallistatin in Salt-Induced Renal Injury, Inflammation, and Fibrosis Via Antioxidative Stress

Microarray Analysis of Gene Expression Profiles in the Kidney Demonstrates Potassium Induced Blood Pressure Decrease

Genetically conditioned interaction among microRNA-155, alpha-klotho, and intra-renal RAS in male rats: Link to CKD progression

Potassium antagonizes damage of coronary artery induced by high salt in-take